---
title: "SNWV.US (SNWV.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SNWV.US/news.md"
symbol: "SNWV.US"
name: "SNWV.US"
parent: "https://longbridge.com/zh-HK/quote/SNWV.US.md"
datetime: "2026-03-14T09:33:26.302Z"
locales:
  - [en](https://longbridge.com/en/quote/SNWV.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNWV.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNWV.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/SNWV.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/SNWV.US/news.md)


# SNWV.US (SNWV.US) — 相關新聞

### [Sanuwave Health Audit Committee Concludes Prior Financial Statements For Multiple Periods Should Not Be Relied Upon](https://longbridge.com/zh-HK/news/279091144.md)
*2026-03-13T20:48:37.000Z*
### [SANUWAVE Health Sets Frequency for Future Executive Compensation Votes](https://longbridge.com/zh-HK/news/272748531.md)
*2026-01-15T21:33:32.000Z*
### [Roth MKM Keeps Their Buy Rating on Sanuwave Health (SNWV)](https://longbridge.com/zh-HK/news/272127057.md)
*2026-01-09T21:56:06.000Z*
> Roth MKM analyst Kyle Bauser has reiterated a Buy rating on Sanuwave Health (SNWV) with a price target of $53.00. Bauser

### [Sanuwave Health Q4 Preliminary Revenue Climbs](https://longbridge.com/zh-HK/news/272061980.md)
*2026-01-09T10:44:01.000Z*
> Sanuwave Health, Inc. (SNWV) announced that it anticipates its Q4 revenue to be between $13.3 million and $13.4 million,

### [Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue | SNWV Stock News](https://longbridge.com/zh-HK/news/272056623.md)
*2026-01-09T02:00:00.000Z*
> Sanuwave Health announced preliminary Q4 2025 revenues of $13.3-$13.4 million, marking a 29-30% increase year-over-year 

### [Frank Morgan C., Director by Deputization, sells common shares of SANUWAVE Health Inc](https://longbridge.com/zh-HK/news/269777614.md)
*2025-12-15T22:23:32.000Z*